Research output per year
Research output per year
Unit profile
Research
Lund Cardio Pulmonary Register (LCPR) was initiated in September 2011 by Göran Rådegran & composes a biobank of blood samples from patients evaluated with right heart catheterization for pulmonary hypertension or severe heart failure, prior to or after medical therapy for pulmonary arterial hypertension (PAH) or heart failure, & after heart transplantation. The aim is to find new biomarkers that can identify; patients with heart failure or high pulmonary artery pressure; who has the greatest benefit of different medical treatments; new targets for treatment & optimal steering of individual treatment, as well as detect rejection following transplantation. Lund Heart Transplantation Research Network (LHTRN) and Lund Pulmonary Hypertension Research Network (LPHRN) was initiated in 2011 by Göran Rådegran to promote research within the field of heart transplantation & pulmonary hypertension at Skåne University hospital (SUS) in Lund.
Description
Lund Hemodynamic Lab was initiated in 2010 by Göran Rådegran in order to provide high quality investigations, essential in risk assessment in guidance of PAH therapies & listing for transplantation & utilizing myocardial biopsies in steering of immunosuppression to prevent rejection after transplantation.
UKÄ subject classification
- Cardiac and Cardiovascular Systems
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Collaborations the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Göran Rådegran
- Lund Hemodynamic Lab - Project manager
- Cardiology - Research team manager, Physician, Supervisor, Associate professor
- Cardiopulmonary disease - information, support and reception - Research project participant
Person
Research output
-
Left ventricular dysfunction in pulmonary arterial hypertension is attributed to underfilling rather than intrinsic myocardial disease: a CMR 2D phase contrast study
Venkateshvaran, A., Bohlin, J., Kjellström, B., Bergström, E., Nelsson, A., Werther Evaldsson, A., Rådegran, G., Arheden, H. & Ostenfeld, E., 2024 Jul 27, In: Scientific Reports. 14, 1, 17280.Research output: Contribution to journal › Article › peer-review
Open Access -
Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Ahmed, S., Ahmed, A. & Rådegran, G., 2024 Jan, In: Pulmonary Circulation. 14, 1, e12340.Research output: Contribution to journal › Letter › peer-review
Open Access -
Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension
Engel Sällberg, A., Helleberg, S., Ahmed, S., Ahmed, A. & Rådegran, G., 2023 Dec, In: ESC Heart Failure. 10, 6, p. 3582-3591 10 p.Research output: Contribution to journal › Article › peer-review
Open Access
-
Plasma proteome profiling in the prognostication and differentiation of pulmonary hypertension
Kania, K., Rådegran, G., Engel Sällberg, A., Ahmed, A., Ahmed, S. & Tran Lundmark, K.
2023/09/01 → …
Project: Dissertation